Breeze away breathlessness: fan therapy tested for heart drug side effect
NCT ID NCT07268859
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a hand fan can prevent or reduce shortness of breath caused by the heart drug ticagrelor. About 110 adults with acute coronary syndrome who are starting ticagrelor will be enrolled. Researchers will track how many people have breathing trouble within two hours of taking the medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sağlık Bilimleri Üniversitesi Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim Araştırma Hastanesi
RECRUITINGIstanbul, Üsküdar, 34668, Turkey (Türkiye)
-
İstanbul Üniversitesi-Cerrahapaşa
NOT_YET_RECRUITINGIstanbul, Avcılar, 34320, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple breath: could guided breathing calm heart failure symptoms?
- Can a touch on the hands ease Asthma's breathlessness and sleeplessness?
- Can a Hand-Based therapy ease COPD's toughest symptoms?
- Can a cholesterol-lowering combo also shrink fatty liver in diabetic heart patients?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- AI could sharpen emergency diagnoses for chest pain and breathing trouble